|
End-of-day quote
NSE India S.E.
|
||
| - INR | - |
|
| 07/03/16 | UCB : Pharma crusader takes India's drug regulators to court | RE |
| 29/06/15 | Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.62% | -2.71% | -0.88% | -3.52% | +6.99% | +39.30% | +113.61% | +400.83% | +1,319.57% | 1,031B | |
| -2.30% | -4.44% | -4.62% | +1.84% | +24.99% | +39.03% | +66.72% | +61.19% | +117.71% | 638B | |
| -0.63% | -1.96% | -0.02% | +3.53% | +13.76% | +6.36% | +75.33% | +138.27% | +311.09% | 462B | |
| -1.03% | -2.82% | -4.04% | +14.71% | +36.62% | +59.56% | +40.23% | +76.67% | +130.02% | 359B | |
| -0.03% | -3.91% | -1.08% | +4.87% | +6.34% | +34.28% | +39.35% | +2.06% | +44.81% | 335B | |
| -1.58% | +0.39% | -4.22% | -6.73% | +7.72% | +17.92% | +25.77% | +53.66% | +54.53% | 273B | |
| -2.02% | -3.20% | +0.52% | -14.67% | -12.75% | +7.60% | +8.38% | +34.32% | +140.45% | 253B | |
| -3.38% | +0.30% | -7.04% | +12.71% | +24.43% | +36.44% | +52.93% | +90.38% | +143.38% | 228B | |
| -1.04% | -1.46% | -1.61% | +17.09% | +20.17% | +32.70% | +99.06% | +115.14% | +89.03% | 185B | |
| -1.26% | -0.89% | -14.50% | -20.53% | -23.14% | -27.46% | -61.17% | -19.54% | +81.55% | 170B | |
| -1.40% | -1.02% | -1.51% | +17.76% | +12.93% | +3.34% | -17.15% | -34.50% | -16.51% | 163B | |
| -3.07% | -2.99% | -7.47% | +1.75% | +11.77% | +25.37% | +45.69% | +180.98% | +483.87% | 133B | |
| -1.51% | -0.07% | -8.16% | +8.89% | +13.94% | +29.58% | +6.24% | +3.28% | +12.44% | 127B | |
| +5.27% | +3.39% | -0.88% | +17.02% | +9.57% | +17.48% | +105.48% | +349.37% | +443.49% | 99.55B | |
| -2.02% | -4.83% | -3.16% | -9.39% | -1.62% | +14.00% | +20.31% | +2.31% | -12.60% | 97.46B | |
| +0.63% | -0.01% | -4.83% | -2.64% | -11.63% | -6.94% | -27.97% | -12.01% | +8.07% | 98.83B | |
| -1.89% | -3.02% | +22.47% | +160.61% | +540.69% | +584.57% | +82.89% | -44.61% | - | 76.88B | |
| -3.09% | -7.69% | -10.80% | +17.62% | -4.80% | +22.48% | -10.17% | +28.74% | +82.42% | 75.72B | |
| -2.64% | +1.13% | -3.27% | -8.44% | +9.67% | +22.84% | -14.99% | -28.35% | +40.18% | 68.18B | |
| Average | -1.00% | +0.05% | -2.90% | +11.18% | +36.09% | +50.45% | +34.24% | +73.59% | +192.97% | 243.66B | |
| Weighted average by Cap. | -0.98% | -0.14% | -2.77% | +4.30% | +19.69% | +36.12% | +55.33% | +134.58% | +390.02% |
- Stock Market
- Stocks
- RANB Stock
- Sector Ranbaxy Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
